Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy
Open Access
- 13 May 2004
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (14) , 1117-1125
- https://doi.org/10.1038/sj.gt.3302268
Abstract
Gene therapy for Duchenne muscular dystrophy has so far not been successful because of the difficulty in achieving efficient and permanent gene transfer to the large number of affected muscles and the development of immune reactions against vector and transgenic protein. In addition, the prenatal onset of disease complicates postnatal gene therapy. We have therefore proposed a fetal approach to overcome these barriers. We have applied β-galactosidase expressing equine infectious anaemia virus (EIAV) lentiviruses pseudotyped with VSV-G by single or combined injection via different routes to the MF1 mouse fetus on day 15 of gestation and describe substantial gene delivery to the musculature. Highly efficient gene transfer to skeletal muscles, including the diaphragm and intercostal muscles, as well as to cardiac myocytes was observed and gene expression persisted for at least 15 months after administration of this integrating vector. These findings support the concept of in utero gene delivery for therapeutic and long-term prevention/correction of muscular dystrophies and pave the way for a future application in the clinic.Keywords
This publication has 24 references indexed in Scilit:
- Correction of the Dystrophic Phenotype byIn VivoTargeting of Muscle Progenitor CellsHuman Gene Therapy, 2003
- Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent miceGene Therapy, 2003
- Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectorsMolecular Therapy, 2003
- Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?Neuromuscular Disorders, 2002
- New Methods to Titrate EIAV-Based Lentiviral VectorsMolecular Therapy, 2002
- High-Level Transduction and Gene Expression in Hematopoietic Repopulating Cells Using a Human Imunodeficiency Virus Type 1-Based Lentiviral Vector Containing an Internal Spleen Focus Forming Virus PromoterHuman Gene Therapy, 2002
- In Utero Delivery of Adeno-Associated Viral Vectors: Intraperitoneal Gene Transfer Produces Long-Term ExpressionMolecular Therapy, 2001
- Stable gene transfer to the nervous system using a non-primate lentiviral vectorGene Therapy, 1999
- Characterization of (+) Strand Initiation and Termination Sequences Located at the Center of the Equine Infectious Anemia Virus GenomeBiochemistry, 1999
- Sustained expression of genes delivered directly into liver and muscle by lentiviral vectorsNature Genetics, 1997